Journal of Neurology

, Volume 258, Issue 5, pp 728–739

Managing MS in a changing treatment landscape

  • Martin Duddy
  • Aiden Haghikia
  • Eleonora Cocco
  • Christian Eggers
  • Jelena Drulovic
  • Olga Carmona
  • Helene Zéphir
  • Ralf Gold
Review

DOI: 10.1007/s00415-011-6009-x

Cite this article as:
Duddy, M., Haghikia, A., Cocco, E. et al. J Neurol (2011) 258: 728. doi:10.1007/s00415-011-6009-x

Abstract

Increasing options are dictating the development of new algorithms to provide guidance in the treatment of people with multiple sclerosis (MS). There is a wealth of evidence on the safety and efficacy of interferon-beta and glatiramer acetate, which have been used in Europe and in the United States for more than 10 years. The spectrum of approved indications for these conventional disease modifying therapies includes the treatment of relapsing-remitting MS, secondary progressive MS, and the clinically isolated syndrome. Beyond these therapies we already have the recently introduced antibody natalizumab and, in some countries, the immunosuppressive agent mitoxantrone. Oral therapies are expected in the near future, with the sphingosin-1-phosphate receptor modulator fingolimod approved in the US and the EU and the purine nucleoside analogue cladribine in Australia and Russia. The evidence on all of these conventional and novel therapeutics is reviewed in this paper to provide an overview of the changing landscape of MS treatment.

Keywords

Multiple sclerosisInterferon-betaGlatiramer acetateMitoxantroneNatalizumabFingolimodCladribine

Copyright information

© Springer-Verlag 2011

Authors and Affiliations

  • Martin Duddy
    • 1
  • Aiden Haghikia
    • 2
  • Eleonora Cocco
    • 3
  • Christian Eggers
    • 4
  • Jelena Drulovic
    • 5
  • Olga Carmona
    • 6
  • Helene Zéphir
    • 7
  • Ralf Gold
    • 2
  1. 1.Department of NeurologyRoyal Victoria InfirmaryNewcastle-upon-TyneUK
  2. 2.Department of NeurologySt. Josef-Hospital/Ruhr-University BochumBochumGermany
  3. 3.Multiple Sclerosis Centre, Department of Cardiovascular and Neurological ScienceUniversity of CagliariCagliariItaly
  4. 4.Department of NeurologyKrankenhaus der Barmherzigen BrüderLinzAustria
  5. 5.Clinic of Neurology, Faculty of MedicineUniversity of BelgradeBelgradeSerbia
  6. 6.Neurology DepartmentHospital de FigueresGironaSpain
  7. 7.Department of NeurologyHôpital R. SalengroLilleFrance